Gaccione is a well-known and respected radiation oncology business development, sales and management executive
SAN FRANCISCO, Calif., Sept. 01, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – American Shared Hospital Services (NYSE American: AMS) (the “Company”), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment, facilities and services, today announced the appointment of Peter Gaccione as Chief Operating Officer (COO), effective September 7, 2022. Mr. Gaccione assumes the role of COO from Craig Tagawa who remains the Company’s President and Chief Financial Officer.
Mr. Gaccione has over 40 years of experience and leadership in the global radiation oncology and imaging industry. Most recently, he was President and a member of the Board of Directors of Myocardial Solutions Inc., a medical technology company in the field of cardiology and cardio-oncology, where he led product marketing, sales, marketing development and clinical teams. Previously, Mr. Gaccione held various positions with Elekta AB, a provider of precision radiation oncology, brachytherapy, neuroscience treatment systems and software solutions from 1997 to 2020, culminating in his position as President and CEO of Elekta Inc. and Elekta Medical SA de CV (Mexico), as well as Executive Vice President of North America and Latin America regions of Elekta and member of the management team of Elekta AB from June 2017 to February 2020.
Ray Stachowiak, President and CEO, said, “We are delighted to welcome Peter Gaccione as Chief Operating Officer of American Shared Hospital Services. Peter has many years of healthcare experience and brings strong market knowledge across the spectrum of radiation oncology. He is well known and respected in our industry and at AMS.
“His addition broadens and strengthens the Company’s management team and growth prospects. We expect Peter’s relationship building skills and extensive professional network, working in concert with Tim Keel’s creative financial transaction abilities, to be a strong combination. Recall that Tim, a senior healthcare finance professional, joined AMS in May 2022 as Vice President of Sales and Marketing. I have great confidence in this expanded team and believe that AMS is well positioned to continue to pursue both photon and proton technologies in the provision of radiation oncology equipment, facilities and services. concluded Mr. Stachowiak.
Mr. Gaccione added, “Throughout my career, I have enjoyed working with the medical community to empower physicians and leaders at major universities, hospitals and multi-modality cancer centers to strive for achieve better patient outcomes by using innovative technologies with creative financial solutions. . At AMS, we have the ability to work with and partner with all major original equipment manufacturers to offer clinical cancer treatment centers the opportunity to work with a turnkey supplier to obtain all of their treatment products. cancer in a creative relationship. This is rare in the field of radiation oncology and one of the main factors in my decision to join the AMS leadership team.
About American Hospital Shared Services (NYSE American: AMS)
American Shared Hospital Services is a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment, facilities and services. AMS is a leading supplier of Gamma Knife radiosurgery equipment, a non-invasive treatment for malignant and benign brain tumors, vascular malformations and trigeminal neuralgia (facial pain). The company also offers proton therapy and the latest IGRT, IMRT and MR/LINAC systems. For more information, visit: www.ashs.com.
Safe Harbor Statement
This press release may be deemed to contain certain forward-looking statements regarding the financial condition, results of operations and future plans of American Shared Hospital Services (including statements regarding the company’s expected continued growth and the expansion of Gamma Company’s Knife, proton therapy and MR/LINAC businesses, which involve risks and uncertainties, including but not limited to risks relating to economic and market conditions, risks of variability in financial results between the quarters, the risks of the Gamma Knife and proton therapy activities, the risks related to the development of The Operating Room for the 21st Century program, the risks of changes in the reimbursement rates or the CMS reimbursement methodology, the risks related to the schedule, financing and operations of the Company’s Gamma Knife, proton therapy and MR/LINAC activities, the risks of the pandemic ie of COVID-19 and its effect on the Company’s business activities and financial condition, the risk of expansion within or into new markets, the risk that the integration or continuation of operations of acquired businesses could adversely affect the financial results and the risk that current and future acquisitions could adversely affect the financial position of the Company. Additional information about potential factors that could affect American Shared Hospital Services’ financial condition, results of operations and future plans is included in the company’s filings with the Securities and Exchange Commission, including the company’s quarterly reports on Form 10-Q for the three-month periods ended March 31, 2022 and June 30, 2022, the annual report on Form 10-K for the year ended December 31, 2021 and the proxy statement of definitive proxies for the annual meeting of shareholders held on June 21, 2022.
American Shared Hospital Services
Chief executive officer
T.: (646) 863-6341